90 reports

  • Drivers of supplier power in the healthcare providers sector in Switzerland, 2019
  • Switzerland healthcare providers sector value: $ billion, 2015-19

Table ##: Switzerland healthcare providers sector value: $ billion, 2015-## Figure ##: Switzerland healthcare providers sector value: $ billion, 2015-## ##.

  • Health Care Provider
  • Healthcare
  • Switzerland
  • Market Size
  • Mediclinic International Limited

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: NETWORK SERVICES, USD
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: OTHERS, USD MILLION, 2016 -

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Switzerland
  • Market Segment
  • Market Size

Most of the healthcare infrastructure and professionals have been delegated to treating COVID-## patients.

  • Healthcare
  • Switzerland
  • Demand
  • F. Hoffmann-La Roche Ltd.
  • Roche Group
  • GALDERMA ACQUIRES PEKIRON CREAM FROM KYORIN PHARMA
  • GALDERMA ENTERS INTO RESEARCH AGREEMENT WITH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI AND NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE

The company' s deal volume decreased from three pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • France
  • Switzerland
  • M&A
  • Galderma S.A.
  • MABXIENCE SA, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018
  • MABXIENCE SA, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

GlobalData mAbxience SA, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Switzerland
  • mAbxience

GlobalData Dottikon ES Holding AG' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company Financials
  • DOTTIKON ES HOLDING AG
  • SPINOMIX RAISES US$3 MILLION IN SERIES A FINANCING
  • IMMUNEXPRESS RAISES US$6 MILLION IN VENTURE FINANCING

Debio-## is a small molecule and selectively targets FGFR ##, ##, ##.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company
  • Debiopharm Group
  • Acino International AG, Subsidiaries

Hoffman-La Roche Ltd. and was sold to and developed by Arpida AG on June ##, 2001.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • M&A
  • Acino Holding Ltd.
  • Aevis Victoria SA, Pharmaceuticals & Healthcare, Deal Details
  • Aevis Victoria SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Aevis Victoria SA, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Healthcare
  • Hospital
  • Switzerland
  • M&A
  • AEVIS Holding SA
  • Medicines for Malaria Venture, Pharmaceuticals & Healthcare, Deal Details
  • Sanofi-Aventis Extends Agreement with Medicines For Malaria Venture

GlobalData Medicines for Malaria Venture reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Malaria
  • Switzerland
  • Company Operations
  • Eisai Co., Ltd.
  • Apr 10, 2017: Mediclinic International: Swiss regulatory update
  • Apr 13, 2017: Mediclinic International: Full Year 2017 Trading Update

The combination of Mediclinic and Al Noor has created one of the leading private healthcare providers in the region.

  • Healthcare
  • Hospital
  • Switzerland
  • Company Financials
  • Mediclinic International Limited
  • Neurimmune Holding AG, Pharmaceuticals & Healthcare, Deal Details

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company
  • Neurimmune

Switzerland Telemedicine Market Forecast to 2022 - By Service Platform (Tele Home & M-Health and Tele Hospital), by Technology Platform (Software and Hardware) and by Clinical Applications ##.

  • E-Healthcare
  • Healthcare
  • Telemedicine
  • Switzerland
  • Market Size

Europe is one of the best regions in world, where healthcare provider is well aligned and diabetes institutional network are properly scattered to capture the whole demography.

  • Healthcare
  • Switzerland
  • United Kingdom
  • Forecast
  • Market Size

Even health care systems with deep pockets might not have sufficient land available, particularly in urban areas.

  • Healthcare
  • Germany
  • Switzerland
  • Hitachi, Ltd.
  • Mitsubishi Corporation
  • FUTURE DEVELOPMENTS
  • COST CONTAINMENT

Inadequate for social healthcare provision.

  • Health Care Provider
  • Health Services
  • Healthcare
  • Hospital
  • Switzerland

GlobalData SGS SA reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Switzerland
  • Company
  • Deals & Alliance
  • SGS Canada Inc.
  • TILLOTTS PHARMA ENTERS INTO LICENSING AGREEMENT WITH NUMAB

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company
  • Tillotts Pharma AG
  • Corporate Communications

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Anti-Infective
  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Polyphor Ltd.
  • HELSINN HEALTHCARE SA, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • Helsinn Healthcare SA, Subsidiaries

GlobalData Deal Type Licensing Agreement Partnerships Venture Financing Asset Purchases No. of Deals ## ## ## ## Deal Value (US$ million) NA NA ##. ## NA Helsinn Healthcare SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 HELSINN

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company
  • Helsinn Group

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Switzerland

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Switzerland
  • PARTNERSHIPS

BioVersys provides one of its most innovative targets focused on gram-negative pathogens into this partnership.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Deals & Alliance
  • Bioversys
  • Anergis SA, Pharmaceuticals & Healthcare, Deal Details
  • Anergis Raises US$9 Million In Venture Financing

GlobalData Anergis SA, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Company
  • Anergis SA

GlobalData Therapy Area Central Nervous System Gastrointestinal Hematological Disorders Immunology Oncology No. of Deals ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA Ewopharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Switzerland
  • Deals & Alliance
  • Redbiotec AG, Pharmaceuticals & Healthcare, Deal Details

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Pharmaceutical
  • Switzerland
  • Deals & Alliance
  • Redbiotec AG

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Switzerland
  • OGD2 Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Region Europe Asia-Pacific North America Middle East and Africa South and Central America No. of Deals ## ## ## NA NA Deal Value (US$ million) NA NA NA NA NA OGD## Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 OGD## Pharma SAS,

  • Healthcare
  • Medical Biotechnology
  • Therapy
  • Switzerland
  • Deals & Alliance
  • PIQUR Therapeutics AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData PIQUR Therapeutics AG, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Therapy
  • Switzerland
  • Company
  • PIQUR Therapeutics AG